THOMPSON SIEGEL & WALMSLEY LLC - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 20 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$70,0004,8000.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Lone Star Value Management LLC 171,661$2,489,0004.72%
1492 Capital Management LLC 56,764$823,0000.67%
GREAT POINT PARTNERS LLC 178,930$2,594,0000.66%
KINGDON CAPITAL MANAGEMENT, L.L.C. 946,223$13,720,0000.63%
Timpani Capital Management LLC 81,815$1,186,0000.47%
683 Capital Management, LLC 187,075$2,713,0000.29%
Lombard Odier Asset Management (USA) Corp 150,000$2,175,0000.20%
Tourbillon Capital Partners, L.P. 237,874$3,449,0000.07%
TFS CAPITAL LLC 10,768$156,0000.04%
ARDSLEY ADVISORY PARTNERS LP 12,295$178,0000.03%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders